TriNetX

Cambridge, United States

TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.

$200.0M raised

Apr 2026

Corporate Round

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has TriNetX raised?

TriNetX has raised $200.0M in total funding. The most recent round was Corporate Round. The last funding was announced in April 2026.

Who are TriNetX's investors?

TriNetX's investors include Regeneron, Deerfield, ITOCHU Technology Ventures, MPM Capital, Mitsui & Co.

Where is TriNetX headquartered?

TriNetX is headquartered in Cambridge, United States.

What does TriNetX do?

TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.

What stage is TriNetX at?

TriNetX is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 2, 2026.

MLA

"TriNetX — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/trinetx. Accessed July 2, 2026.

APA

VCBacked. (2026). TriNetX — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/trinetx

Wikipedia (cite web)

{{cite web |title=TriNetX — Funding & Investors |url=https://www.vcbacked.co/company/trinetx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 2, 2026.